We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medica... read more Featured Products: More products

Download Mobile App




Two Automated Hematology Analyzers Compared for Performance

By LabMedica International staff writers
Posted on 17 Dec 2020
Print article
Image: The Yumizen H2500 Automatic Hematology Analyzer (Photo courtesy of Horiba)
Image: The Yumizen H2500 Automatic Hematology Analyzer (Photo courtesy of Horiba)
A complete blood count (CBC) is a highly automated laboratory test. The use of highly advanced measurement methods increases the accuracy and sensitivity of the determination of individual hematological parameters, especially in the case of white blood cells differentiation.

It is important that the results of laboratory tests obtained using automated analyzers, which are currently able to perform more than 1,000 tests per day, are comparable, repeatable and reliable regardless of the analyzer used and the laboratory in which the analysis was performed.

Medical Laboratorians at the Medical University of Warsaw (Warsaw, Poland) collected 241 peripheral blood samples from adult patients. Samples of peripheral blood came from both healthy patients and those suffering from various pathologies. To perform comparative analysis of hematological parameters, complete blood count with leukocyte differentiation (CBC+ 5-DIFF) and a complete blood count (CBC) without leukocyte differentiation were used.

The complete blood count results were obtained using two automated hematology analyzers: the XN-2000 (Sysmex Corporation, Kobe, Japan) and the Yumizen H2500 (Horiba, Kyoto, Japan). The XN-2000 uses the following methods of fluorescent flow to determine all tested hematological parameters: cytometry, impedance and optical cytometry. Impedance method to count red blood cells (RBC) and platelets, and has an optical measurement channel for reticulocytes in which platelet count can also be measured. The Yumizen H2500 is a quantitative, multi-parameter, automatic hematological analyzer. It uses the double hydrodynamic focusing method, which includes measurement of polychromatic light absorbance and the impedance method.

The scientists reported that reliable leukocyte differentiation results were obtained for blood samples in which the number of white blood cells perceived using an automatic hematological analyzer was within the detection limits for both analyzers. Statistically significant differences were found for four hematological parameters: eosinophil count, immature granulocytes, mean corpuscular hemoglobin concentration (MCHC) and platelet distribution width (PDW).

The comparative study showed agreement between measurements of complete blood count parameters such as leukocyte count (WBC), red blood cell count (RBC), hemoglobin concentration (HGB), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (mean cell hemoglobin, MCH), red blood cell distribution width (RDW), platelet count (PLT), mean platelet volume (MPV), and plateletcrit (PCT).

The authors concluded that due to the existence of variability between the results obtained from different hematology analyzers, it is recommended that patient samples be analyzed in the same laboratory using the same analyzer, in order to avoid obtaining divergent results that could be misinterpreted. Incorrect interpretation may affect further clinical management and be a source of uncertainty. The study was published in the November, 2020 issue of the journal Practical Laboratory Medicine.

Related Links:
Medical University of Warsaw
Sysmex Corporation
Horiba


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
C-Reactive Protein Assay
OneStep C-Reactive Protein (CRP) RapiCard InstaTest
New
Amoebiasis Test
ELI.H.A Amoeba

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.